Literature DB >> 24196628

[c-MYC-mediated regulations in colorectal cancer].

A Menssen1.   

Abstract

In the majority of human tumors the oncogenic transcription factor c-MYC is deregulated and contributes to the formation of many biologically important tumor properties. These include the induction of cell cycle progression, transformation, genomic instability and immortalization. So far it was unclear which target genes of c-MYC mediate the effects. Using genome-wide approaches we identified a large number of c-MYC target genes. Subsequently, we characterized some target genes for their role in c-MYC-induced genomic instability and immortalization. The protein deacetylase SIRT1 was found to be an important mediator of c-MYC-induced immortalization. Using in situ analyses of colorectal cancer specimens we demonstrated that c-MYC is a regulator of the identified target genes in human tumors thus implicating their relevance for tumorigenesis in humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24196628     DOI: 10.1007/s00292-013-1819-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  12 in total

1.  Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.

Authors:  Beibei Mao; Guowei Zhao; Xiang Lv; Hou-Zao Chen; Zheng Xue; Ben Yang; De-Pei Liu; Chih-Chuan Liang
Journal:  Int J Biochem Cell Biol       Date:  2011-07-22       Impact factor: 5.085

2.  Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis.

Authors:  Hongfeng Yuan; Zhiqiang Wang; Ling Li; Hao Zhang; Hardik Modi; David Horne; Ravi Bhatia; WenYong Chen
Journal:  Blood       Date:  2011-12-29       Impact factor: 22.113

3.  Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes.

Authors:  Antje Menssen; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

4.  c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability.

Authors:  Antje Menssen; Alexey Epanchintsev; Dmitri Lodygin; Nousin Rezaei; Peter Jung; Berlinda Verdoodt; Joachim Diebold; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-02-03       Impact factor: 4.534

5.  SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.

Authors:  D Herranz; A Maraver; M Cañamero; G Gómez-López; L Inglada-Pérez; M Robledo; E Castelblanco; X Matias-Guiu; M Serrano
Journal:  Oncogene       Date:  2012-09-17       Impact factor: 9.867

6.  SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas.

Authors:  Kyu Yun Jang; Sang Jae Noh; Nadja Lehwald; Guo-Zhong Tao; David I Bellovin; Ho Sung Park; Woo Sung Moon; Dean W Felsher; Karl G Sylvester
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

7.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

8.  SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability.

Authors:  Glenn M Marshall; Pei Y Liu; Samuele Gherardi; Christopher J Scarlett; Antonio Bedalov; Ning Xu; Nuncio Iraci; Emanuele Valli; Dora Ling; Wayne Thomas; Margo van Bekkum; Eric Sekyere; Kacper Jankowski; Toby Trahair; Karen L Mackenzie; Michelle Haber; Murray D Norris; Andrew V Biankin; Giovanni Perini; Tao Liu
Journal:  PLoS Genet       Date:  2011-06-16       Impact factor: 5.917

9.  c-MYC and SIRT1 locked in a vicious cycle.

Authors:  Antje Menssen; Heiko Hermeking
Journal:  Oncotarget       Date:  2012-02

10.  Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer.

Authors:  Lydia Kriegl; Michael Vieth; Thomas Kirchner; Antje Menssen
Journal:  Oncotarget       Date:  2012-10
View more
  2 in total

1.  Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis.

Authors:  Maoyu Li; Fang Peng; Guoqing Li; Yang Fu; Ying Huang; Zhuchu Chen; Yongheng Chen
Journal:  Oncotarget       Date:  2016-06-14

2.  POFUT1 promotes colorectal cancer development through the activation of Notch1 signaling.

Authors:  Yuheng Du; Daojiang Li; Nanpeng Li; Chen Su; Chunxing Yang; Changwei Lin; Miao Chen; Runliu Wu; Xiaorong Li; Gui Hu
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.